Ho Chi-Chun, Fong Wai-Ying, Lee Yuen-Hon, Poon Wing-Tat
Department of Clinical Pathology, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong, China.
Genes (Basel). 2017 Oct 23;8(10):285. doi: 10.3390/genes8100285.
Thiopurines are clinically useful in the management of diverse immunological and malignant conditions. Nevertheless, these purine analogues can cause lethal myelosuppression, which may be prevented by prospective testing for variants in the thiopurine S-methyltransferase () and, in East Asians, Nudix hydrolase 15 () genes. Two single-tube, tetra-primer amplification refractory mutation system polymerase chain reaction (ARMS-PCR) assays were developed to genotype the common loss-of-function variants c.415C>T (rs116855232) and c.719A>G (rs1142345). In a group of 60 unselected patients, one and seven were found to be homozygous and heterozygous, respectively, for c.415C>T; one was found to be heterozygous for c.719A>G. There was no non-specific amplification, and the genotypes were 100% concordant with Sanger sequencing. Limit-of-detection for both assays was below 1 ng of heterozygous template per reaction. Time- and cost-effective ARMS-PCR assays, suitable for genotyping East-Asian patients for thiopurine intolerance, were successfully developed and validated.
硫嘌呤在多种免疫性和恶性疾病的治疗中具有临床应用价值。然而,这些嘌呤类似物可导致致命的骨髓抑制,通过对硫嘌呤S-甲基转移酶(TPMT)以及东亚人群中的Nudix水解酶15(NUDT15)基因变异进行前瞻性检测,或许可以预防这种情况。开发了两种单管、四引物扩增阻滞突变系统聚合酶链反应(ARMS-PCR)检测方法,用于对常见的功能丧失性变异TPMT c.415C>T(rs116855232)和NUDT15 c.719A>G(rs1142345)进行基因分型。在一组60例未经选择的患者中,分别发现1例为TPMT c.415C>T纯合子,7例为杂合子;发现1例为NUDT15 c.719A>G杂合子。未出现非特异性扩增,且基因分型结果与桑格测序结果100%一致。两种检测方法的检测限均低于每个反应1 ng杂合模板。成功开发并验证了适用于对东亚患者进行硫嘌呤不耐受基因分型的具有时间和成本效益的ARMS-PCR检测方法。